4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000012
CEO bought 174,000 shares at an average $0.02 ($3,932)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
29 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-14 | Purchase : show line 1 in the form | +5,000 | $0.02 | $110 | 21,367,123 | D |
| 2019-02-14 | Purchase : show line 2 in the form | +5,000 | $0.02 | $110 | 21,372,123 | D |
| 2019-02-14 | Purchase : show line 3 in the form | +5,000 | $0.02 | $109 | 21,377,123 | D |
| 2019-02-14 | Purchase : show line 4 in the form | +10,000 | $0.02 | $219 | 21,387,123 | D |
| 2019-02-14 | Purchase : show line 5 in the form | +10,000 | $0.02 | $219 | 21,397,123 | D |
| 2019-02-14 | Purchase : show line 6 in the form | +5,000 | $0.02 | $109 | 21,402,123 | D |
| 2019-02-14 | Purchase : show line 7 in the form | +5,000 | $0.02 | $111 | 21,407,123 | D |
| 2019-02-14 | Purchase : show line 8 in the form | +5,000 | $0.02 | $110 | 21,412,123 | D |
| Open-market purchases · 174,000 sh · avg $0.02 · $3,932 | ||||||
Loading xslF345X03/primary_doc.xml…